New strategy for monitoring targeted therapy: molecular imaging
Open Access
- 1 September 2013
- journal article
- review article
- Published by Informa UK Limited in International Journal of Nanomedicine
- Vol. 8, 3703-13
- https://doi.org/10.2147/IJN.S51264
Abstract
Peer reviewed article authored by (Teng FF, Meng X, Sun XD, Yu JM). Read article or submit your manuscript for publishing.Keywords
This publication has 86 references indexed in Scilit:
- Positron Emission Tomography Imaging of Vascular Endothelial Growth Factor Receptor Expression with 61Cu-Labeled Lysine-Tagged VEGF121Molecular Pharmaceutics, 2012
- Measurement of Tumor VEGF-A Levels with 89Zr-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft ModelClinical Cancer Research, 2012
- A Triple‐Targeted Ultrasound Contrast Agent Provides Improved Localization to Tumor VasculatureJournal of Ultrasound in Medicine, 2011
- MRI with Magnetic Nanoparticles Monitors Downstream Anti-Angiogenic Effects of mTOR InhibitionMolecular Imaging & Biology, 2010
- Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[18F]-Fluoro-L-Thymidine ([18F]FLT) Positron Emission Tomography (PET)PLOS ONE, 2008
- US Imaging of Tumor Angiogenesis with Microbubbles Targeted to Vascular Endothelial Growth Factor Receptor Type 2 in MiceRadiology, 2008
- Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET.2006
- Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic diseaseBritish Journal of Cancer, 2005
- Molecular-genetic imaging: current and future perspectives.2003